1,3-Bis(4‘,4‘-dimethyl-2‘-oxazolinyl)benzene ( 5a ) and 5-nitro-1,3-bis(4‘,4‘-dimethyl-2‘-oxazolinyl)benzene ( 5b ) were heated in dry acetic acid with K 2 PtCl 4 to give the corresponding 2,6-bis(4‘,4‘-dimethyl-2‘-oxazolinyl)phenylplatinum(II) chloride complexes 6a and 6b in 49 and 11% yield, respectively. The X-ray structure of 6b is reported. The main side product observed in the platination of 5a was identified as di(2-methyl-2- N -acetyl)propyl isophthalate. In contrast, use of Pd(OAc) 2 with 5a in this protocol, followed by addition of LiBr, gave 2,6-bis(4‘,4‘-dimethyl-2‘-oxazolinyl)phenylpalladium(II) bromide in only 3% yield. Treatment of 6a with AgOTf and AgSbF 6 in acetone gave quantitatively the corresponding cationic 2,6-bis(4‘,4‘-dimethyl-2‘-oxazolinyl)phenyl(aquo)platinum(II) complexes 15a and 15b . Similarly treatment of 6b with AgOTf in acetone gave 4-nitro-2,6-bis(4‘,4‘-dimethyl-2‘-oxazolinyl)phenyl(aquo)platinum(II) trifluoromethanesulfonate ( 15c ) (72%). Complexes 15a − c, together with 2,6-bis(4‘,4‘-dimethyl-2‘-oxazolinyl)phenylaquopalladium(II) triflate ( 15d ), were applied as catalysts for the Michael reaction between methyl vinyl ketone and ethyl cyanoacetate and the Diels−Alder reaction between acrylonitrile and cyclopentadiene. In both cases platinum complex 15a was found to be the most active, with the 4-nitro group of 15c resulting in decreased catalytic activity.
No takes yet. Share an insight, caveat, or question.
Fossey et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: